Nestlé enters exclusive talks to sell skin health unit to private equity firm for $10.1B

Nestlé, a Swiss consumer goods giant, has entered exclusive talks to sell its skin health business to a consortium led by private equity firm EQT Partners for $10.1 billion, according to The Wall Street Journal.

Advertisement

The consumer goods manufacturer announced in September it was exploring options for the skin health unit, including a sale, as an effort to reshape its product portfolio. 

Nestlé’s skin health business includes acne-care products like Proactive and Cetaphil.

The sale of the skin-health business to the consortium led by EQT Partners is expected to close in the second half of this year.

The consortium includes EQT Partners, a unit of the Abu Dhabi Investment Authority and PSP Investments.

More articles on pharmacy:
8 recent pharmaceutical lawsuits, settlements
McKesson renews distribution deal with CVS Health
Sacklers discussed selling Purdue Pharma in 2000, court documents reveal

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.